Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravenous Immunoglobulin and Prednisolone to Women With Unexplained Recurrent Pregnancy Loss After Assisted Reproductive Technology Treatment: a Randomised, Double-blind, Placebo-controlled Trial

NCT04701034 is registered in ClinicalTrials.gov with Aalborg University Hospital as lead sponsor.

NCT NCT04701034
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04701034 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravenous Immunoglobulin and Prednisolone to Women With Unexplained Recurrent Pregnancy Loss After Assisted Reproductive Technology Treatment: a Randomised, Double-blind, Placebo-controlled Trial
Lead sponsor
Aalborg University Hospital
Phase
Phase 2
Overall status
Completed
Start date
January 28, 2021
Completion date
April 18, 2024
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fertility disorders, habitual abortion, miscarriage, recurrent pregnancy loss